Compare HOOD & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOOD | GSK |
|---|---|---|
| Founded | 2013 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.6B | 102.0B |
| IPO Year | 2021 | N/A |
| Metric | HOOD | GSK |
|---|---|---|
| Price | $117.00 | $50.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 2 |
| Target Price | ★ $121.14 | N/A |
| AVG Volume (30 Days) | ★ 22.0M | 3.3M |
| Earning Date | 02-10-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.28% |
| EPS Growth | ★ 304.26 | 118.57 |
| EPS | ★ 2.39 | 1.79 |
| Revenue | $4,204,000,000.00 | ★ $43,237,357,842.00 |
| Revenue This Year | $54.96 | $6.70 |
| Revenue Next Year | $23.18 | $5.10 |
| P/E Ratio | $50.90 | ★ $28.31 |
| Revenue Growth | ★ 74.58 | 2.73 |
| 52 Week Low | $29.66 | $31.72 |
| 52 Week High | $153.86 | $51.46 |
| Indicator | HOOD | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 45.30 | 67.41 |
| Support Level | $110.41 | $48.59 |
| Resistance Level | $124.35 | $51.46 |
| Average True Range (ATR) | 4.58 | 0.56 |
| MACD | 0.21 | 0.08 |
| Stochastic Oscillator | 46.99 | 74.36 |
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.